Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anticonvulsants market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anticonvulsantsmarket, defines the market attractiveness level of Anticonvulsants market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anticonvulsants industry, describes the types of Anticonvulsants market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anticonvulsants market and the development prospects and opportunities of Anticonvulsants industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anticonvulsants market in Chapter 13.
By Player:
GlaxoSmithKline plc
Abbott Laboratories
Shire plc
Novartis AG
Cephalon Inc
UCB Group
Pfizer Inc
Johnson & Johnson (J&J)
By Type:
Epilepsy
Fibromyalgia
Migraine
Neuropathic pain
Bipolar disorder
Anxiety
Borderline personality disorder
By End-User:
Borderline personality disorder
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anticonvulsants Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anticonvulsants Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anticonvulsants Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anticonvulsants Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anticonvulsants Market Analysis and Outlook to 2022
-
7.1 Global Anticonvulsants Consumption (2017-2022)
-
7.2 United States Anticonvulsants Consumption (2017-2022)
-
7.3 Europe Anticonvulsants Consumption (2017-2022)
-
7.4 China Anticonvulsants Consumption (2017-2022)
-
7.5 Japan Anticonvulsants Consumption (2017-2022)
-
7.6 India Anticonvulsants Consumption (2017-2022)
-
7.7 South Korea Anticonvulsants Consumption (2017-2022)
8 Region and Country-wise Anticonvulsants Market Analysis and Outlook to 2028
-
8.1 Global Anticonvulsants Consumption Forecast (2022-2028)
-
8.2 United States Anticonvulsants Consumption Forecast (2022-2028)
-
8.3 Europe Anticonvulsants Consumption Forecast (2022-2028)
-
8.4 China Anticonvulsants Consumption Forecast (2022-2028)
-
8.5 Japan Anticonvulsants Consumption Forecast (2022-2028)
-
8.6 India Anticonvulsants Consumption Forecast (2022-2028)
-
8.7 South Korea Anticonvulsants Consumption Forecast (2022-2028)
9 Global Anticonvulsants Market Outlook by Types and Applications to 2022
-
9.1 Global Anticonvulsants Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Epilepsy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Fibromyalgia Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Migraine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Neuropathic pain Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Bipolar disorder Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Anxiety Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Borderline personality disorder Consumption and Growth Rate (2017-2022)
-
9.2 Global Anticonvulsants Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Borderline personality disorder Consumption and Growth Rate (2017-2022)
10 Global Anticonvulsants Market Outlook by Types and Applications to 2028
-
10.1 Global Anticonvulsants Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Fibromyalgia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Migraine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Neuropathic pain Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Bipolar disorder Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Anxiety Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Borderline personality disorder Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anticonvulsants Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Borderline personality disorder Consumption Forecast and Growth Rate (2022-2028)
11 Global Anticonvulsants Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anticonvulsants Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anticonvulsants Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anticonvulsants Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anticonvulsants Market Competitive Analysis
-
14.1 GlaxoSmithKline plc
-
14.1.1 GlaxoSmithKline plc Company Details
-
14.1.2 GlaxoSmithKline plc Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline plc Anticonvulsants Product and Service
-
14.2 Abbott Laboratories
-
14.2.1 Abbott Laboratories Company Details
-
14.2.2 Abbott Laboratories Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Abbott Laboratories Anticonvulsants Product and Service
-
14.3 Shire plc
-
14.3.1 Shire plc Company Details
-
14.3.2 Shire plc Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Shire plc Anticonvulsants Product and Service
-
14.4 Novartis AG
-
14.4.1 Novartis AG Company Details
-
14.4.2 Novartis AG Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis AG Anticonvulsants Product and Service
-
14.5 Cephalon Inc
-
14.5.1 Cephalon Inc Company Details
-
14.5.2 Cephalon Inc Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Cephalon Inc Anticonvulsants Product and Service
-
14.6 UCB Group
-
14.6.1 UCB Group Company Details
-
14.6.2 UCB Group Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 UCB Group Anticonvulsants Product and Service
-
14.7 Pfizer Inc
-
14.7.1 Pfizer Inc Company Details
-
14.7.2 Pfizer Inc Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Inc Anticonvulsants Product and Service
-
14.8 Johnson & Johnson (J&J)
-
14.8.1 Johnson & Johnson (J&J) Company Details
-
14.8.2 Johnson & Johnson (J&J) Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Johnson & Johnson (J&J) Anticonvulsants Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anticonvulsants
-
Figure Anticonvulsants Picture
-
Table Global Anticonvulsants Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anticonvulsants Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anticonvulsants Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anticonvulsants Consumption by Country (2017-2022)
-
Figure United States Anticonvulsants Consumption and Growth Rate (2017-2022)
-
Table Europe Anticonvulsants Consumption and Growth Rate (2017-2022)
-
Figure China Anticonvulsants Consumption and Growth Rate (2017-2022)
-
Figure Japan Anticonvulsants Consumption and Growth Rate (2017-2022)
-
Figure India Anticonvulsants Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anticonvulsants Consumption and Growth Rate (2017-2022)
-
Figure Global Anticonvulsants Consumption Forecast by Country (2022-2028)
-
Figure United States Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Epilepsy Consumption and Growth Rate (2017-2022)
-
Figure Global Fibromyalgia Consumption and Growth Rate (2017-2022)
-
Figure Global Migraine Consumption and Growth Rate (2017-2022)
-
Figure Global Neuropathic pain Consumption and Growth Rate (2017-2022)
-
Figure Global Bipolar disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Anxiety Consumption and Growth Rate (2017-2022)
-
Figure Global Borderline personality disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Borderline personality disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fibromyalgia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Migraine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neuropathic pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bipolar disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anxiety Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Borderline personality disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Borderline personality disorder Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anticonvulsants Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anticonvulsants Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Anticonvulsants Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Anticonvulsants Product and Service
-
Table Shire plc (Foundation Year, Company Profile and etc.)
-
Table Shire plc Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire plc Anticonvulsants Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Anticonvulsants Product and Service
-
Table Cephalon Inc (Foundation Year, Company Profile and etc.)
-
Table Cephalon Inc Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cephalon Inc Anticonvulsants Product and Service
-
Table UCB Group (Foundation Year, Company Profile and etc.)
-
Table UCB Group Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Group Anticonvulsants Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Anticonvulsants Product and Service
-
Table Johnson & Johnson (J&J) (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson (J&J) Anticonvulsants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson (J&J) Anticonvulsants Product and Service
-
